Introduction of a Simple Second Tier Screening Test for C5 Isobars in Dried Blood Spots: Reducing the False Positive Rate for Isovaleric Acidaemia in Expanded Newborn Screening.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  JIMD Reports

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/8904_2017_33PMID 28631226PMCID PMC5874210
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surprising causes of C5-carnitine false positive results in newborn screening.

  2014cited by this paper
• Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases

  2014cited by this paper
• Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria.

  2014cited by this paper
• Impact of new screening technologies: should we screen and does phenotype influence this decision?

  2013cited by this paper
• A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening.

  2004cited by this paper
• Diagnosis of isovaleric acidaemia by tandem mass spectrometry: False positive result due to pivaloylcarnitine in a newborn screening programme

  1998cited by this paper
• Identification of the molecular defects responsible for the various genotypes of isovaleric acidemia.

  1992cited by this paper
• Isovaleric acidemia: personal history, clinical survey and study of the molecular basis.

  1990cited by this paper

• Practical Considerations for the Diagnosis and Management of Isovaleryl-CoA-Dehydrogenase Deficiency (Isovaleric Acidemia): Systematic Search and Review and Expert Opinions

  2025cites this paper
• Newborn Screening for Isovaleric Acidemia: Treatment With Pivalate‐Generating Antibiotics Contributed to False C5‐Carnitine Positivity in a Chinese Population

  2024cites this paper
• Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK

  2024influential citation
• Validation of a targeted metabolomics panel for improved second‐tier newborn screening

  2023cites this paper
• Analysis of a second-tier test panel in dried blood spot samples using liquid chromatography-tandem mass spectrometry in Catalonia’s newborn screening programme

  2023cites this paper
• A Simple Flow Injection Analysis–Tandem Mass Spectrometry Method to Reduce False Positives of C5-Acylcarnitines Due to Pivaloylcarnitine Using Reference Ions

  2022cites this paper
• Neonatal screening for isovaleric aciduria: Reducing the increasingly high false‐positive rate in Germany

  2022cites this paper
• Incorporating second-tier genetic screening for multiple acyl-CoA dehydrogenase deficiency.

  2022cites this paper
• [New Inborn Errors of Metabolism added in the French program of neonatal screening].

  2021cites this paper
• Impacto de la inclusión de pruebas de segundo nivel en el programa de cribado neonatal de Cataluña y en otros programas internacionales.

  2020cites this paper
• Newborn screening for isovaleric acidemia in Quanzhou, China.

  2020cites this paper
• Development of Strategies to Decrease False Positive Results in Newborn Screening

  2020cites this paper
• Essential oils can cause false-positive results of medium-chain acyl-CoA dehydrogenase deficiency

  2020cites this paper
• Raising Awareness of False Positive Newborn Screening Results Arising from Pivalate-Containing Creams and Antibiotics in Europe When Screening for Isovaleric Acidaemia

  2018cites this paper
• Falsos positivos en cribado neonatal: Elevación de C5-carnitina en neonatos por tratamiento preparto con cefditoreno pivoxilo

  2018cites this paper